Role of DNA Repair Variants and Diagnostic Radiology Exams in Differentiated Thyroid Cancer Risk: A Pooled Analysis of Two Case-Control Studies.
Monia ZidaneThérèse TruongFabienne LesueurConstance XhaardEmilie Cordina-DuvergerAnne BolandHélène BlanchéCatherine OrySylvie ChevillardJean-François DeleuzeVincent SouchardYan RenMohammed Zakarya ZemmacheSandra CanaleFrançoise Borson-ChazotClaire SchvartzEugènia Mariné BarjoanAnne-Valérie GuizardPierre Laurent-PuigClaire MulotJulie GuibonMojgan KarimiMartin SchlumbergerElizabeth AdjadjCarole RubinoPascal GuénelJean-Baptiste CazierFlorent de VathairePublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2021)
CDH2, NFATc2, ENOSF1/THYS, and RPA3 have not previously been shown to be associated with DTC risk.